Purple Biotech Ltd   (PPBT)

Working costs have been on the rise at the company in the fiscal period closing December 31 2022

company reported fourth quarter of 2022 operating deficit of $-22.603 million

Published Mar 23 2023
Goran Soko / CSIMarket.com Contributer

Autosample_takes_a_By_Hey_Paul_(originally_posted_to_Flickr_as_image4)_[CC-BY-SA-2.0_(http_creativecommons.org_licenses_by-sa_2.0)]_via_Wikimedia_Commons The stockholders did not expect any adjustments at the business during the the October to December 31 2022 reporting cycle at the PPBT. But, they monitor the company's operating deficit that was at $-22.603 million, during the same period.

The operating deficit has contracted from $-17.934 million, from the fourth quarter of 2021. But more crucially, the analysts are guessing, if the Purple Biotech Ltd s' will start to report the revenue.

It was a good financial reporting period for the entity, although the company has not clinched any revenues so far. So in what way we should measure, if it was an encouraging quarter, the net profits surged from $18.468 million in the a year ago, to $21.760 million, in the fiscal period closing December 31 2022.

PPBT reported shortfall of $21.76 million and revenue of $0.00 million in the fiscal period 2022.

The Major Pharmaceutical Preparations company reported further 0 compared to $0.00 in the previous fiscal year, while by 0 % from $0.00 million a year ago.

Purple Biotech Ltd is expected to report next financial recent numbers on March 02, 2024.

Purple Biotech Ltd's Dividend Payout

Purple Biotech Ltd's Free Cash Flow Margin

Other PPBT's Earnings Reports

Other PPBT's Earnings Reports


About us


CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com